Skip to Main Content

Author Details

Jennifer C Nelson
Kaiser Permanente Washington Health Research Institute
1998
109
39
PMIDPaper TitleJournal TitlePublished Year
36007092Validation of Acute Pancreatitis Among Adults in an Integrated Healthcare System.Epidemiology2023
37479610Safety signal identification for COVID-19 bivalent booster vaccination using tree-based scan statistics in the Vaccine Safety Datalink.Vaccine2023
37926397Racial and ethnic disparities in influenza vaccination coverage among pregnant women in the United States: The contribution of vaccine-related attitudes.Prev Med2023
37057157Analysis of the 24-h activity cycle: An illustration examining the association with cognitive function in the Adult Changes in Thought study.Front Psychol2023
37204791COVID-19 Booster Vaccination in Early Pregnancy and Surveillance for Spontaneous Abortion.JAMA Netw Open2023
37167612Medically Attended Acute Adverse Events in Pregnant People After Coronavirus Disease 2019 (COVID-19) Booster Vaccination.Obstet Gynecol2023
36481108Tree-based data mining for safety assessment of first COVID-19 booster doses in the Vaccine Safety Datalink.Vaccine2023
36535825A broad assessment of covid-19 vaccine safety using tree-based data-mining in the vaccine safety datalink.Vaccine2023
36928091COVID-19 Vaccine Safety Surveillance in Early Pregnancy in the United States: Design Factors Affecting the Association Between Vaccine and Spontaneous Abortion.Am J Epidemiol2023
36331289Improving Methods of Identifying Anaphylaxis for Medical Product Safety Surveillance Using Natural Language Processing and Machine Learning.Am J Epidemiol2023
36193854Active Postlicensure Safety Surveillance for Recombinant Zoster Vaccine Using Electronic Health Record Data.Am J Epidemiol2023
35226533In older adults, use of a recombinant zoster vaccine was associated with Guillain-Barré syndrome.Ann Intern Med2022
35581698Safety of COVID-19 Vaccination in United States Children Ages 5 to 11 Years.Pediatrics2022
35731916Evaluation of Acute Adverse Events after Covid-19 Vaccination during Pregnancy.N Engl J Med2022
35471572Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink.JAMA Netw Open2022
35465977Changes in incidence rates of outcomes of interest in vaccine safety studies during the COVID-19 pandemic.Vaccine2022
35428497Dashboard development for near real-time visualization of COVID-19 vaccine safety surveillance data in the vaccine safety datalink.Vaccine2022
36577134Extended surveillance to assess safety of 9-valent human papillomavirus vaccine.Hum Vaccin Immunother2022
35902278Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination.Vaccine2022
35960522Health Care Utilization in the 6 Months Following SARS-CoV-2 Infection.JAMA Netw Open2022
36349537Kawasaki Disease Following the 13-valent Pneumococcal Conjugate Vaccine and Rotavirus Vaccines.Pediatrics2022
34264911COVID-19 Vaccination Coverage Among Insured Persons Aged â¿¥16 Years, by Race/Ethnicity and Other Selected Characteristics - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021.MMWR Morb Mortal Wkly Rep2021
33515414Safety of Dalbavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI): Nephrotoxicity Rates Compared with Vancomycin: A Post Hoc Analysis of Three Clinical Trials.Infect Dis Ther2021
33591057Identification and Validation of Anaphylaxis Using Electronic Health Data in a Population-based Setting.Epidemiology2021
34931012Broadening the reach of the FDA Sentinel system: A roadmap for integrating electronic health record data in a causal analysis framework.NPJ Digit Med2021
34409675Letter to the Editor re Beachler, et al, 2021.Pharmacoepidemiol Drug Saf2021
34477808Surveillance for Adverse Events After COVID-19 mRNA Vaccination.JAMA2021
32841986Consequences of Depletion of Susceptibles for Hazard Ratio Estimators Based on Propensity Scores.Epidemiology2020
31823406Safety surveillance and the estimation of risk in select populations: Flexible methods to control for confounding while targeting marginal comparisons via standardization.Stat Med2020
33376449Multiply robust causal inference with double-negative control adjustment for categorical unmeasured confounding.J R Stat Soc Series B Stat Methodol2020
33156197Evaluating the Association of Stillbirths After Maternal Vaccination in the Vaccine Safety Datalink.Obstet Gynecol2020
31108199Leveraging the entire cohort in drug safety monitoring: part 1 methods for sequential surveillance that use regression adjustment or weighting to control confounding in a multisite, rare event, distributed data setting.J Clin Epidemiol2019
31740498Near Real-Time Surveillance to Assess the Safety of the 9-Valent Human Papillomavirus Vaccine.Pediatrics2019
31055178Applying sequential surveillance methods that use regression adjustment or weighting to control confounding in a multisite, rare-event, distributed setting: Part 2 in-depth example of a reanalysis of the measles-mumps-rubella-varicella combination vaccine and seizure risk.J Clin Epidemiol2019
29318683Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel System.Pharmacoepidemiol Drug Saf2018
29862604Safety of repeated doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine in adults and adolescents.Pharmacoepidemiol Drug Saf2018
29504168Sequential surveillance for drug safety in a regulatory environment.Pharmacoepidemiol Drug Saf2018
29254838The impact of selection bias on vaccine effectiveness estimates from test-negative studies.Vaccine2018
28349171Intersections of poverty, race/ethnicity, and sex: alcohol consumption and adverse outcomes in the United States.Soc Psychiatry Psychiatr Epidemiol2017
27418432Design and analysis choices for safety surveillance evaluations need to be tuned to the specifics of the hypothesized drug-outcome association.Pharmacoepidemiol Drug Saf2016
27713904A Synthesis of Current Surveillance Planning Methods for the Sequential Monitoring of Drug and Vaccine Adverse Effects Using Electronic Health Care Data.EGEMS (Wash DC)2016
22138688Methods for observational post-licensure medical product safety surveillance.Stat Methods Med Res2015
26034240Physician Communication Training and Parental Vaccine Hesitancy: A Randomized Trial.Pediatrics2015
25496703Using winter 2009-2010 to assess the accuracy of methods which estimate influenza-related morbidity and mortality.Epidemiol Infect2015
25510526Simulation study comparing exposure matching with regression adjustment in an observational safety setting with group sequential monitoring.Stat Med2015
25560438Safety of measles-containing vaccines in 1-year-old children.Pediatrics2015
24699471Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine.Vaccine2014
25263307Characteristics of study design and elements that may contribute to the success of electronic safety monitoring systems.Pharmacoepidemiol Drug Saf2014
24843064Timely versus delayed early childhood vaccination and seizures.Pediatrics2014
24714919Systemic inflammation and brachial artery endothelial function in the Multi-Ethnic Study of Atherosclerosis (MESA).Heart2014
  • 1 - 50 of 109

Recommended Authors

University of California Los Angeles
Career Start Year 2017
Number of shared co-authors 0
the Perelman School of Medicine, University of Pennsylvania
Career Start Year 2015
Number of shared co-authors 1
Center for Pediatric Clinical Effectiveness, The Children's Hospital of Philadelphia
Career Start Year 2014
Number of shared co-authors 0
Center for Clinical Investigation, Brigham and Women's Hospital
Career Start Year 2014
Number of shared co-authors 1
University of California los angeles
Career Start Year 2013
Number of shared co-authors 0
The University of Manchester, University of Manchester
Career Start Year 2013
Number of shared co-authors 3
Vanderbilt University Medical Center
Career Start Year 2011
Number of shared co-authors 0
Janssen Pharmaceutical Research and Development
Career Start Year 2010
Number of shared co-authors 3
University of Pennsylvania
Career Start Year 2006
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 2005
Number of shared co-authors 5
University of Pittsburgh School of Public Health
Career Start Year 2004
Number of shared co-authors 2
Harvard Medical School
Career Start Year 2004
Number of shared co-authors 2
Vanderbilt University Medical Center
Career Start Year 2002
Number of shared co-authors 4
Oregon Health & Science University-Portland State University School of Public Health
Career Start Year 2002
Number of shared co-authors 0
Pennsylvania State University-Milton S. Hershey Medical Center
Career Start Year 2001
Number of shared co-authors 0
David Geffen School of Medicine, University of California los angeles
Career Start Year 1998
Number of shared co-authors 1
University of Washington
Career Start Year 1998
Number of shared co-authors 1
Clalit Health Services, Ben Gurion University
Career Start Year 1998
Number of shared co-authors 1
Vanderbilt University Medical Center.
Career Start Year 1997
Number of shared co-authors 10
Stanford University
Career Start Year 1997
Number of shared co-authors 4
Baylor College of Medicine
Career Start Year 1997
Number of shared co-authors 4
Medical University of South Carolina
Career Start Year 1996
Number of shared co-authors 1
University of Florida
Career Start Year 1996
Number of shared co-authors 1
McGill University
Career Start Year 1994
Number of shared co-authors 2
University of Michigan ann arbor
Career Start Year 1991
Number of shared co-authors 0
University of Bristol
Career Start Year 1988
Number of shared co-authors 3
University of Pennsylvania Perelman School of Medicine
Career Start Year 1985
Number of shared co-authors 1
Massachusetts General Hospital
Career Start Year 1982
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 1982
Number of shared co-authors 9
Center for Pharmacoepidemiology and Treatment Science, Rutgers University
Career Start Year 1970
Number of shared co-authors 8

Collaborators

Kaiser Permanente Washington Health Research institute
Co-authored papers 9
Marshfield Clinic Research Institute
Co-authored papers 9
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 9
Harvard Medical School and Harvard Pilgrim Health Care Institute
Co-authored papers 9
Harvard Pilgrim Health Care Institute and Harvard Medical School
Co-authored papers 7
Kaiser Permanente Southern California
Co-authored papers 6
Division of Pharmacoepidemiology, Brigham & Women's Hospital, Harvard Medical School
Co-authored papers 6
University of Washington
Co-authored papers 5
Cardiovascular Health Research Unit, University of Washington
Co-authored papers 5
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital
Co-authored papers 5
Center for Drug Evaluation and Research
Co-authored papers 5
University of Washington
Co-authored papers 5
Co-authored papers 5
Kaiser Permanente Washington Health Research Institute
Co-authored papers 5
Co-authored papers 5
University of Washington
Co-authored papers 4
Center for Drug Evaluation and Research
Co-authored papers 4
Kaiser Permanente Washington Health Research Institute
Co-authored papers 4
Rollins School of Public Health, Emory University
Co-authored papers 4
Harvard T.H. Chan School of Public Health
Co-authored papers 3
University of Washington
Co-authored papers 3
University of California los angeles
Co-authored papers 3
Department of Medicine University of California Davis Davis CA USA.
Co-authored papers 3
OHDSI Center at The Roux Institute, Northeastern University
Co-authored papers 2
University of Iowa, School of Public Health
Co-authored papers 2
Duke Clinical Research Institute
Co-authored papers 2
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Harvard Medical School and Harvard Pilgrim Health Care Institute
Co-authored papers 2